Expression of drug pathway proteins is independent of tumour type

The Journal of Pathology
W ZhangH L McLeod

Abstract

Current clinicopathological staging systems have the advantage of standardized criteria for assessing tumour stage, and a relationship between advancing tumour stage and poor prognosis has been established for most cancers. However, these tools have not led to clear criteria for therapy selection in individual patients. Indeed, the concept of therapy based on anatomical location seems quaint. Therefore, a representative drug pathway (irinotecan) was evaluated across common tumour types to test the hypothesis that pharmacological proteins are expressed independent of anatomical location. Many enzymes are involved in controlling the disposition of irinotecan, including the cellular target (TOP1), metabolism enzymes (CES2, UGT1A1, CYP3A4, CYP3A5), and cellular transporters of the anti-cancer agent (ABCB1, ABCC1, ABCC2, ABCC3, ABCC5, ABCG2). These 11 proteins were evaluated in tissue microarrays containing colon, breast, prostate, ovary, and lung cancers; brain tumours; melanoma; lymphoma; and selected normal tissues. A total of 255 tumours and 37 normal tissue samples were evaluable for all proteins. Linear discriminant analysis designed to predict the tissue type from the protein expression levels revealed a 49.6% misclassificati...Continue Reading

References

Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·T AndohK Okada
Aug 1, 1996·British Journal of Cancer·H L McLeod, W N Keith
Jul 17, 1997·International Journal of Cancer. Journal International Du Cancer·K AogiT Andoh
Aug 27, 1998·The New England Journal of Medicine·C H Pui, W E Evans
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark J Ratain
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lawrence H Einhorn
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Dec 14, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Forrest D HsuC Blake Gilks
May 16, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Min Jong LeeMihi Yang
Dec 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard M GoldbergSteven R Alberts
Dec 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Britta WeigeltLaura J van't Veer
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yixin WangDavid Atkins
Oct 8, 2004·Pharmacogenomics·Sharon Marsh, Howard L McLeod
Nov 4, 2004·Journal of the National Cancer Institute·Ron H J MathijssenAlex Sparreboom

❮ Previous
Next ❯

Citations

Jul 20, 2007·Blood·Cristina Rodríguez-AntonaBeatriz Martínez-Delgado
Nov 22, 2007·Expert Opinion on Drug Metabolism & Toxicology·Michael Michael, Margaret M Doherty
Mar 29, 2014·Drug Metabolism Reviews·Tereza Kunická, Pavel Souček
Jun 26, 2007·Biochemical Pharmacology·Heather M LeitnerBrian J Day
May 23, 2014·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Abigail V RutterJosep Sulé-Suso
Aug 31, 2011·Pathology·John M Nicholls, Glenn D Francis
Jul 28, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Syed Subhani, Kaiser Jamil
Nov 26, 2013·The Journal of Steroid Biochemistry and Molecular Biology·Subrata DebEmma S Tomlinson Guns
Mar 7, 2007·Clinical Pharmacology and Therapeutics·K M GiacominiUNKNOWN Pharmacogenetics Research Network
Sep 8, 2010·Journal of Industrial Microbiology & Biotechnology·D PalmeroJ C Tello
Dec 11, 2019·British Journal of Cancer·Christiane A OpitzSaskia Trump
Aug 21, 2020·Cell Biochemistry and Function·Yun ChenDan Su
Jul 1, 2016·Personalized Medicine·Lisa GrünmüllerJochen K Lennerz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.